STING1 and neoplasm: MITA activation by tumor DNA elicits anti-tumor immunity by type I IFN induction and tumor antigen presentation by DCs [32], whereas MITA-mediated inflammation promotes tumorigenesis in an inflammation-induced skin cancer model [70].